Keyphrases
Hepatitis C Virus
77%
Hepatitis C Virus Genotypes
50%
Recombinant
41%
Genotype 1
37%
JFH1
35%
Virus
32%
Cell Culture Model
31%
Protease Inhibitors
24%
COVID-19
20%
NS5A
19%
Cell Culture
17%
Genotype 3
17%
Genotype
15%
NS5A Inhibitor
15%
Huh7.5 Cells
15%
Neutralizing Antibodies
14%
Genotype 2a
14%
Culture System
10%
Genetic Parameters
10%
Interferon-α (IFN-α)
9%
Escape Variants
9%
High Titer
8%
5′-untranslated Region (5′-UTR)
8%
Virus Production
8%
Hepatitis C Virus Inhibitors
8%
Resistance-associated Substitutions
7%
NS5B
7%
Genotype 5
7%
Sofosbuvir
7%
Adaptive mutation
7%
Infectivity Titer
7%
High Efficiency
7%
Vaccine Development
7%
Virus Neutralization
7%
Genotype 4
6%
NS3/4A Protease
6%
Reverse Genetics
5%
Viral Life Cycle
5%
Scavenger Receptor Class B Type 1 (SR-B1)
5%
Hypervariable Region
5%
Bioreactor
5%
Remdesivir
5%
Vaccine Response
5%
Neutralization Activity
5%
Hepatitis C Virus RNA
5%
Direct-acting Antivirals
5%
Polymerase Inhibitors
5%
Hepatitis C
5%
Virus Envelope
5%
Antiviral Resistance
5%
Immunology and Microbiology
Hepatitis C Virus
100%
Cell Culture
53%
Vaccine Efficacy
25%
NS5A
24%
Neutralizing Antibody
18%
Titer
18%
Hepatitis C Virus Genotype 1
18%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
NS5A Inhibitors
13%
Neutralization
12%
Hepatitis C
10%
NS5B
10%
Recombinant Virus
10%
Monospecific Antibody
10%
Mouse
9%
Epitope
8%
Sofosbuvir
8%
interferon
7%
Bioreactor
7%
CD81
6%
Hypervariable Region
5%
Viral Life Cycle
5%
Virus Neutralization
5%
Virus Vaccine
5%
Antiviral Resistance
5%
Untranslated Region
5%
Virus Particle
5%
Cell Density
5%
Viral Envelope
5%
Scavenger Receptor
5%
